Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of TSPO in Glucose Metabolism (G-TSPO)
NCT07682233Phase 2Recruiting
- Sponsor
- Imperial College London
- Start
- Mar 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of emapunil in type 2 diabetes mellitus (T2DM), sponsored by Imperial College London. Started Mar 2026; status: recruiting.
02
Drugs
emapunil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07682233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682233.